Vaccinex, Inc. (VCNX)

Every figure this model derived for VCNX, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2024-12-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 22,000 PaymentsToAcquirePropertyPlantAndEquipment 2024-12-31
cash 1,107,000 CashAndCashEquivalentsAtCarryingValue 2024-12-31
current assets 2,531,000 AssetsCurrent 2024-12-31
current liabilities 5,084,000 LiabilitiesCurrent 2024-12-31
equity -2,488,000 StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest 2024-12-31
interest expense 2,000 InterestExpense 2024-12-31
ocf -16,186,000 NetCashProvidedByUsedInOperatingActivities 2024-12-31
revenue 601,000 RevenueFromContractWithCustomerExcludingAssessedTax 2024-12-31
sbc 341,000 ShareBasedCompensation 2024-12-31

The ratios

The figures themselves rather than their scores — what somebody looking up VCNX on one particular measure came for.

RatioValue
current ratio0.5
current ratio reported0.5
deferred revenue growth-100.0
dilution pct351.3
growth cv2.68
interest cover-9367.5
revenue growth5.44
revenue growth per share-76.64
rule of 40-3111.87
sbc pct revenue56.74

What to be careful about

What this model itself distrusts about VCNX's figures. Written by the derivation as it ran, not added afterwards.